September 18, 2025

Asure Software Inc (ASUR) Stock Analysis: A Promising 70% Upside Potential for Investors

Asure Software Inc (NASDAQ: ASUR), a cloud-based Human Capital Management (HCM) software provider based in Austin, Texas, is capturing the attention of investors with a compelling 70.78% potential upside, according..

Zhengye Biotechnology Holding L (ZYBT): A Closer Look at Its Market Position and Growth Challenges

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector, specializes in the research, development, manufacture, and sale of veterinary vaccines primarily in China. With a market capitalization..

Canopy Growth Corporation (CGC) Stock Analysis: Exploring Future Prospects in the Healthcare Sector

Canopy Growth Corporation (NASDAQ: CGC) stands as a prominent player in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic products. With operations spanning Canada,..

XOMA Royalty Corporation (XOMA) Stock Analysis: Assessing an 89.62% Upside Potential in the Biotech Sector

For investors navigating the biotechnology sector, XOMA Royalty Corporation (NASDAQ: XOMA) presents an intriguing opportunity. As a biotech royalty aggregator based in Emeryville, California, XOMA is uniquely positioned within the..

Neuronetics, Inc. (STIM) Stock Analysis: Unpacking the 128% Upside Potential

Neuronetics, Inc. (NASDAQ: STIM), a key player in the medical devices sector, is attracting investor interest with its notable potential upside. Specializing in neurohealth disorders, the U.S.-based company’s innovative approach..

Mereo BioPharma Group plc (MREO) Stock Analysis: Exploring the 316% Upside Potential

Mereo BioPharma Group plc (NASDAQ: MREO) has caught the attention of investors with a staggering potential upside of 316.04%. As a company operating in the high-stakes sector of biotechnology, Mereo..

Immutep Limited (IMMP) Stock Analysis: Exploring a 468.86% Potential Upside in Biotech Innovations

Immutep Limited (NASDAQ: IMMP) is capturing the attention of investors with its promising biotech portfolio, highlighted by a staggering potential upside of 468.86%. Headquartered in Sydney, Australia, Immutep operates within..

Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis: Exploring a 188% Potential Upside in the Biotech Sector

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) sits at the intriguing intersection of promising drug development and financial challenges, capturing the attention of investors keen on the biotech sector. Currently priced at..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Promising 15.72% Potential Upside in the Biotech Sector

Palvella Therapeutics, Inc. (PVLA), a cutting-edge player in the biotechnology industry, is garnering significant attention from investors thanks to its innovative approach to treating rare genetic skin diseases. With its..

Pacific Biosciences of California (PACB) Stock Analysis: Is the Potential 71.63% Upside Worth the Risk?

Investors seeking opportunities in the healthcare sector, particularly within the medical devices industry, might want to take a closer look at Pacific Biosciences of California, Inc. (NASDAQ: PACB). Headquartered in..

Senseonics Holdings, Inc. (SENS): Investor Outlook Reveals a Potential 219.55% Upside

For investors with an eye on the healthcare sector, Senseonics Holdings, Inc. (NYSEAMERICAN: SENS) presents a fascinating opportunity within the medical devices industry. Known for its innovative continuous glucose monitoring..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Exploring the Biotech’s Future with a 1.97% Potential Upside

In the dynamic realm of biotechnology, iTeos Therapeutics, Inc. (NASDAQ: ITOS) stands out as a clinical-stage biopharmaceutical company with a focused mission on developing immuno-oncology therapeutics. As it navigates the..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Exploring a 143.61% Potential Upside

A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology company listed in the software application industry, has been attracting investor interest due to its innovative approach to retail automation. With a..

Rigel Pharmaceuticals, Inc. (RIGL)

⚠️ No article content returned.

..

Porch Group, Inc. (PRCH) Stock Analysis: Strong Buy Ratings Drive Investor Optimism Amidst 3.65% Upside Potential

Porch Group, Inc. (NASDAQ: PRCH), a burgeoning player in the technology sector, has captured the attention of investors with its impressive market cap of $1.89 billion. Specializing in software applications,..

Sanara MedTech Inc. (SMTI) Growth Potential: A 46% Upside Awaits in the Healthcare Sector

Sanara MedTech Inc. (SMTI), a prominent player in the healthcare sector specializing in medical instruments and supplies, is drawing attention from investors with its impressive growth metrics and future potential...

AMTD Digital Inc. (HKD): Navigating Challenges and Opportunities in the Tech Sector

AMTD Digital Inc. (NYSE: HKD), a Paris-based technology company, is carving out a unique niche within the software application industry. With a market capitalization of $575.13 million, the company offers..

Quhuo Limited (QH) Stock Analysis: Navigating the Challenges in the Gig Economy Sector

Quhuo Limited (NASDAQ: QH) stands as a notable player within the technology sector, specifically catering to the gig economy through its operations in the software application industry. Based in Beijing,..

Nerdy Inc. (NRDY) Investor Outlook: Unpacking a 60.76% Potential Upside

Nerdy Inc. (NYSE: NRDY), a key player in the technology sector specializing in software applications, presents a compelling case for investors looking at its current valuation and future potential. As..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: A Promising 55.24% Upside in the Medical Device Sector

In the competitive landscape of regenerative medicine, SANUWAVE Health, Inc. (NASDAQ: SNWV) is carving a niche with its innovative medical devices. As a healthcare entity headquartered in Eden Prairie, Minnesota,..

Search

Funds

September 18, 2025

Search

Funds

September 18, 2025

FTSE 100

Funds